Our US-Based Support team is available to help. Contact Us Now
Phone: 800-441-1045 | Email: support@kidneyhood.org
Kidneyhood is the world's first integrated, clinically proven kidney disease management program — combining a very low protein diet, Albutrix keto acid analog supplementation, and Microtrix nutrition.
Recommended by KDIGO 2024 and KDOQI 2020 guidelines. Proven in human patients. Available worldwide without a prescription.
92%
of patients reduced BUN levels*
80%
of patients improved GFR/eGFR*
86%
of patients lowered creatinine levels*
25%
average GFR/eGFR improvement*
Early data is a published 31-person pilot. Compare your labs with that early dataset — a free chapter is emailed to you.
* Reflects average improvement from baseline to six months.
Any statements here have not been evaluated by the FDA. Many factors will affect the results of each patient, stage of kidney disease, dietary compliance, type of kidney disease, comorbid conditions and current health are examples of these factors.
Albutrix Is Protein Formulated for Kidney Patients — It Is a Medical Food, Not a Supplement
If you have CKD, you have likely been advised to limit protein. That guidance is correct — and recent advances in nutritional science have made it possible to go further, more safely, with better outcomes.
When the body processes protein, it produces nitrogen waste that kidneys must filter. In CKD, that filtration load accelerates damage. Standard protein supplements — whey, plant protein, amino acid blends — all generate significant nitrogen waste and are not appropriate for CKD patients on a low protein protocol.
Albutrix is different. As a keto acid analog, it provides all the essential amino acids your body needs from protein — through a metabolic pathway that generates far less nitrogen. Your body gets complete nutrition. Your kidneys get meaningful relief.
Albutrix is protein formulated for kidney patients. It is a medical food, not a supplement. It gives you what protein gives you, with less waste for the kidneys to clear. Early human data is a published 31-person pilot. It is early. KDIGO and KDOQI recommend a very low protein diet with keto acid analogs. In many countries Albutrix is the only one patients can actually buy.
Recommended by the World's Leading Nephrology Organizations
Both KDIGO 2024 (Kidney Disease: Improving Global Outcomes) and KDOQI 2020 (National Kidney Foundation) recommend very low protein diets supplemented with keto acid analogs for CKD patients at risk of progression.
KDIGO 2024 Practice Point 3.3.1.2 states: patients willing and able to follow a structured protocol should consider 'a very low-protein diet (0.3-0.4 g/kg body weight/d) supplemented with essential amino acids or ketoacid analogs.' KDOQI gives this same approach its highest evidence rating: Grade 1A.
The Kidneyhood program — Albutrix + Microtrix + the Kidneyhood very low protein diet — is specifically designed to implement this recommendation. The program is built so a patient can follow the KDIGO/KDOQI very low protein diet with keto acid analogs. Early data is the published 31-person pilot. We will not wait, and we will not skip the data.
Learn How the Kidneyhood Program Fulfills KDIGO & KDOQI Recommendations
Albutrix Is Guaranteed to Be the Best in the World on Nitrogen, Magnesium, and Calcium Content, or Your Money Back
The Highest Rated and Best Selling Kidney Disease Book Series Designed for Patients With More Than 5,000 Reviews
Success Stories
The education of Art, 20%+ improvement in GFR
David's experience with dialysis and message to fellow kidney patients
The education of Jim and his doctor (GFR 11 to 19)
Jason: Kidney patient progress report (GFR 44 to 56)
Liz's story about improving her GFR
Kidney patient review of our Stopping Kidney Disease book
US-BASED SUPPORT
Still Have Questions?
FDA-REGISTERED & USA MADE